Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 8240.0 | 57 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 104.0 | 55 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 323.0 | 62 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 2788.0 | 50 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 9729.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 14056.0 | 59 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | GRO-a | 13362.0 | 53 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 3061.0 | 68 | |
N2645 | TNF-a | 100 | ng/mL | 4 | GRO-a | 2375.0 | 47 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 12282.0 | 39 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | GRO-a | 12566.5 | 52 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GRO-a | 177.5 | 38 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | GRO-a | 377.0 | 41 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GRO-a | 45.0 | 46 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | GRO-a | 47.0 | 55 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GRO-a | 1250.0 | 49 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | GRO-a | 3986.5 | 58 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | GRO-a | 475.0 | 43 | ||||
RA2159 | 4 | GRO-a | 834.5 | 44 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | GRO-a | 55.0 | 48 | ||||
N2645 | 4 | GRO-a | 78.5 | 50 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | GRO-a | 4963.5 | 36 | ||||
RA2708 | 4 | GRO-a | 5370.0 | 38 | |||||||
RA2159 | 4 | GRO-a | 522.0 | 16 | |||||||
N2645 | 4 | GRO-a | 54.0 | 49 |